Angimmune (United States)

Recent papers from Angimmune (United States)

1. Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinomaScientific Reports · 2023
2. Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell CarcinomaBiology · 2022
3. Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific ChallengesBioMed Research International · 2017
4. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expressionCancer Biology & Therapy · 2015
5. Resimmune, an anti-CD3  recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphomaHaematologica · 2015
6. An Anti‐PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and TherapyAdvanced Healthcare Materials · 2012
7. Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell LymphomaCurrent Drug Targets · 2009